Neurology

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes

By Dror Shir, Nick Corriveau-Lecavalier, David Thomas Jones, Neill R. Graff-Radford

Study in peoplePopulations

The paper

Dror Shir, Nick Corriveau-Lecavalier, David Thomas Jones, Neill R. Graff-Radford

Mayo Clinic

Neurology, 5 Aug 2026

doi.org/10.1212/wnl.0000000000218347 PubMed 42555876

medRxiv4 Oct 2026
Remote digital test flags cognitive impairment in older adults
Neurology4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults
Journal of Neurology7 Oct 2026
Brain thinning detected before dementia in people under 65
Annals of Neurology4 Oct 2026
Plasma pTau217 and recall test refine prognosis in Down syndrome